HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes
for Type 2 Diabetes
25 locations incl. Canoga Park
Sponsor: Housey Healthcare ULC
Sex: All·Age: 18+
Code: NCT07546929·Phase 2·Recruiting·Listed Apr 2026
Velocity Clinical Research, Dallas
Clinical research site in Dallas, Texas
Part of Velocity Clinical Research
As of July 2026, 10 paid clinical trials are recruiting at Velocity Clinical Research, Dallas in Dallas, Texas. Active studies at this site cover conditions such as Type 2 Diabetes, Hypercholesterolemia and Obesity. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at Velocity Clinical Research, Dallas (10)
A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia
for Hypercholesterolemia
30 locations incl. Anaheim
Sponsor: Regeneron Pharmaceuticals
Sex: All·Age: 18 - 80
Code: NCT07477704·Phase 2·Recruiting·Listed Mar 2026
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
for Obesity
41 locations incl. Tuscaloosa
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT07321886·Phase 3·Recruiting·Listed Jan 2026
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
for Type 2 Diabetes
60 locations incl. Chandler
Sponsor: Sparrow Pharmaceuticals
Sex: All·Age: 18+
Code: NCT07296484·Phase 2·Recruiting·Listed Dec 2025
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
for Overweight
60 locations incl. Birmingham
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT07282600·Phase 3·Recruiting·Listed Dec 2025
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
for Obesity
26 locations incl. Gilbert
Sponsor: Eli Lilly and Company
Sex: All·Age: 18 - 75
Code: NCT07215559·Phase 2·Recruiting·Listed Oct 2025
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
for Obesity
43 locations incl. Chandler
Sponsor: Eli Lilly and Company
Sex: All·Age: 18 - 75
Code: NCT06143956·Phase 2·Recruiting·Listed Nov 2023
Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes
for Diabetes Mellitus, Type 1
57 locations incl. Scottsdale
Sponsor: vTv Therapeutics
Sex: All·Age: 18+
Code: NCT06334133·Phase 3·Recruiting·Listed Mar 2024
Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes
for Type 2 Diabetes Mellitus
37 locations incl. Birmingham
Sponsor: Endogenex, Inc.
Sex: All·Age: 22 - 70
Code: NCT06267391·Recruiting·Listed Feb 2024
A Study of mRNA-1018-H5 Pandemic Influenza Vaccine in Healthy Adults
for Influenza
10 locations incl. San Bernardino
Sponsor: ModernaTX, Inc.
Sex: All·Age: 18+·Accepts healthy volunteers
Code: NCT07496450·Phase 3·Recruiting·Listed Mar 2026
More research sites in Dallas
- University of Texas Southwestern Medical Center (189 trials)
- UT Southwestern Medical Center (168 trials)
- UT Southwestern/Simmons Cancer Center-Dallas (73 trials)
- University of Texas Southwestern (63 trials)
- Baylor University Medical Center (43 trials)
- Medical City Dallas Hospital (26 trials)
- The University of Texas Southwestern Medical Center (25 trials)
- Parkland Memorial Hospital (24 trials)
- Mary Crowley Cancer Research (23 trials)
- UT Southwestern (23 trials)